• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国心房颤动、口服抗凝剂处方及栓塞性中风的趋势

Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.

作者信息

Guelker Jan-Erik, Bufe Alexander, Klues Heinrich, Shin Dong-In, Blockhaus Christian, Gabriel Nils-Holger, Haverkamp Wilhelm, Kroeger Knut

机构信息

Heartcentre Niederrhein, Department of Cardiology, Helios Clinic Krefeld, Germany; Institute for Heart and Circulation Research, University Cologne, Germany.

Heartcentre Niederrhein, Department of Cardiology, Helios Clinic Krefeld, Germany; Institute for Heart and Circulation Research, University Cologne, Germany; University of Witten/Herdecke, Germany.

出版信息

Cardiovasc Revasc Med. 2019 May;20(5):399-402. doi: 10.1016/j.carrev.2018.07.019. Epub 2018 Jul 21.

DOI:10.1016/j.carrev.2018.07.019
PMID:30115560
Abstract

BACKGROUND

The aim of the study was to compare trends in frequency of atrial fibrillation (AF) with the prescription rates of oral anticoagulants (OAC) and the incidence of embolic stroke (ES) from 2005 through 2014.

METHODS

Annual numbers of hospitalized patients with AF and ES were extracted from the Federal Bureau of Statistics. Defined daily doses (DDD) of prescribed OAC among outpatients were extracted from the insurance drug information system.

RESULTS

The number of cases hospitalized with the diagnosis AF increased continuously by 78.3% (1.25 Million in 2005 to 2.19 Million in 2014, p < 0.001), likewise frequency of ES increased by 89.0% (from 46,068 to 87,050, p < 0.001) and the number of prescribed DDD of OAC almost doubled by 105.4% (from 271,328 to 557,281, p < 0.001). There is an almost linear correlation between occurrence of AF and ES (R = 0.9683). In contrast association between prescription rate of OAC and incidence of ES is not linear as there was a disproportional increase in OAC prescriptions beginning in the year 2010 that is not accompanied by a reduction of cases hospitalized with ES.

CONCLUSIONS

Our analysis of drug treatment rates for OAC in outpatients and hospitalization rates for ES revealed a disproportional increase in prescription of OAC beginning in the year 2010 that does not affect the number of cases hospitalized with ES.

摘要

背景

本研究的目的是比较2005年至2014年期间心房颤动(AF)的发生频率、口服抗凝剂(OAC)的处方率以及栓塞性卒中(ES)的发病率趋势。

方法

从联邦统计局提取每年因AF和ES住院的患者数量。从保险药品信息系统中提取门诊患者中OAC的规定日剂量(DDD)。

结果

诊断为AF的住院病例数持续增加了78.3%(从2005年的125万例增加到2014年的219万例,p<0.001),同样ES的发生频率增加了89.0%(从46068例增加到87050例,p<0.001),OAC的规定DDD数量几乎翻了一番,增加了105.4%(从271328例增加到557281例,p<0.001)。AF和ES的发生之间几乎呈线性相关(R=0.9683)。相比之下,OAC处方率与ES发病率之间的关联不是线性的,因为从2010年开始OAC处方量不成比例地增加,而ES住院病例数并未减少。

结论

我们对门诊患者OAC药物治疗率和ES住院率的分析显示,从2010年开始OAC处方量不成比例地增加,但这并未影响ES住院病例数。

相似文献

1
Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.德国心房颤动、口服抗凝剂处方及栓塞性中风的趋势
Cardiovasc Revasc Med. 2019 May;20(5):399-402. doi: 10.1016/j.carrev.2018.07.019. Epub 2018 Jul 21.
2
Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.急性缺血性脑卒中合并已知心房颤动患者的药物性卒中预防的时间趋势。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105266. doi: 10.1016/j.jstrokecerebrovasdis.2020.105266. Epub 2020 Sep 10.
3
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.以色列诊断为心房颤动后 3 个月内口服抗凝治疗的使用情况:一项基于人群的研究。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1356-1363. doi: 10.1111/jce.14452. Epub 2020 Apr 1.
4
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.装置检测到的心房颤动抗凝治疗的处方变化与结局的实践差异。
Circulation. 2019 May 28;139(22):2502-2512. doi: 10.1161/CIRCULATIONAHA.118.038988. Epub 2019 Mar 17.
5
The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department.急诊科房颤患者的口服抗凝剂应用。
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104599. doi: 10.1016/j.jstrokecerebrovasdis.2019.104599. Epub 2020 Jan 27.
6
Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.在心房颤动患者中从维生素 K 拮抗剂转换为非维生素 K 拮抗剂口服抗凝剂:预测因素、模式和时间趋势。
BMC Cardiovasc Disord. 2021 Oct 13;21(1):493. doi: 10.1186/s12872-021-02295-w.
7
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.探讨澳大利亚新南威尔士州圣约翰霍克斯伯里地区卫生中心为房颤患者开具的抗凝药物质量。
J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):46-53. doi: 10.1177/1074248418786264. Epub 2018 Jul 1.
8
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.维生素 K 拮抗剂和直接口服抗凝剂在预防心房颤动患者中风中的应用不足:当代综述。
Clin Pharmacol Ther. 2018 Aug;104(2):301-310. doi: 10.1002/cpt.1024. Epub 2018 Feb 13.
9
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.直接口服抗凝剂使用的时间变化与其有效性和安全性的关系
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005894. doi: 10.1161/CIRCOUTCOMES.119.005894. Epub 2020 Mar 12.
10
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.老年房颤患者抗凝处方的相关因素
Eur J Prev Cardiol. 2019 Apr;26(6):660-663. doi: 10.1177/2047487318795237. Epub 2018 Aug 28.

引用本文的文献

1
Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands.荷兰新发非瓣膜性心房颤动患者特征、抗凝治疗和预后的时间趋势。
JAMA Netw Open. 2023 Apr 3;6(4):e239973. doi: 10.1001/jamanetworkopen.2023.9973.
2
Polypharmacy occurrence and the related risk of premature death among older adults in Denmark: A nationwide register-based cohort study.丹麦老年人多药治疗的发生情况和与过早死亡相关的风险:一项基于全国登记的队列研究。
PLoS One. 2022 Feb 23;17(2):e0264332. doi: 10.1371/journal.pone.0264332. eCollection 2022.
3
Mortality in atrial fibrillation. Is it changing?
心房颤动患者的死亡率:是否有所变化?
Trends Cardiovasc Med. 2021 Nov;31(8):469-473. doi: 10.1016/j.tcm.2020.10.010. Epub 2020 Oct 27.
4
[The investigation of health outcomes in the German National Cohort: the most relevant endpoints and their assessment].德国国民队列健康结局调查:最相关的终点指标及其评估
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):376-384. doi: 10.1007/s00103-020-03111-0.
5
Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.抗血栓治疗的应用及其与心房颤动患者中风发生率的相关性:来自德国大型索赔数据库的研究结果。
Clin Res Cardiol. 2019 Sep;108(9):1042-1052. doi: 10.1007/s00392-019-01437-7. Epub 2019 Feb 15.